10-Q Filing

Dominari Holdings Inc. CIK: 12239 Q3 2021

Filing Information

Form Type	10-Q
Accession Number	`0001213900-21-058070`
Period End Date	20210930
Filing Date	20211110
Fiscal Year	2021
Fiscal Period	Q3
XBRL Instance	f10q0921_aikidopharma_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 58 Income Statement 52 Cash Flow Statement 67 Stockholders Equity 29

Balance Sheet 58 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.71M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.95M	USD	Point-in-time
Marketable securities	`MarketableSecurityCurrent`	$80.53M	USD	Point-in-time
Marketable securities	`MarketableSecurityCurrent`	$24.80M	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$215.00K	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$644.00K	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Short-term investment	`ShortTermInvestments`	$6.27M	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Short-term investment	`ShortTermInvestments`	-	USD	Point-in-time
Deposits	`DepositsAssetsCurrent`	-	USD	Point-in-time
Deposits	`DepositsAssetsCurrent`	$4.42M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	89.68M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$27.73M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$97.81M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	34.92M	shares	Point-in-time
Convertible note receivable	`NotesReceivableRelatedPartiesNoncurrent`	$2.11M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	89.68M	shares	Point-in-time
Convertible note receivable	`NotesReceivableRelatedPartiesNoncurrent`	-	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	34.92M	shares	Point-in-time
Investments	`Investments`	$2.76M	USD	Point-in-time
Investments	`Investments`	$5.07M	USD	Point-in-time
Total assets	`Assets`	$30.50M	USD	Point-in-time
Total assets	`Assets`	$104.98M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.57M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$567.00K	USD	Point-in-time
Accrued salaries and benefits	`EmployeeRelatedLiabilitiesCurrent`	$237.00K	USD	Point-in-time
Accrued salaries and benefits	`EmployeeRelatedLiabilitiesCurrent`	$310.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$877.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.81M	USD	Point-in-time
Total liabilities	`Liabilities`	$877.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$1.81M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $.0001 par value, 50,000,000 Authorized	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.0001 par value, 50,000,000 Authorized	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 89,681,149 and 34,920,222 shares issued at September 30, 2021 and December 31, 2020, respectively; 89,681,146 and 34,920,219 shares outstanding at September 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$3.00K	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 89,681,149 and 34,920,222 shares issued at September 30, 2021 and December 31, 2020, respectively; 89,681,146 and 34,920,219 shares outstanding at September 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$9.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$265.39M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$186.48M	USD	Point-in-time
Treasury stock, at cost, 3 shares at September 30, 2021 and December 31, 2020	`TreasuryStockValue`	$264.00K	USD	Point-in-time
Treasury stock, at cost, 3 shares at September 30, 2021 and December 31, 2020	`TreasuryStockValue`	$264.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-161.96M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-156.60M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$103.17M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$31.49M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$103.08M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$29.21M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$10.53M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$29.62M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$104.98M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$30.50M	USD	Point-in-time

Income Statement 52 line items

Line Item	Tag	Value	Unit	Period
General and administrative	`SellingGeneralAndAdministrativeExpense`	$5.23M	USD	3 Qtrs
General and administrative	`SellingGeneralAndAdministrativeExpense`	$1.68M	USD	1 Quarter
General and administrative	`SellingGeneralAndAdministrativeExpense`	$734.00K	USD	1 Quarter
General and administrative	`SellingGeneralAndAdministrativeExpense`	$3.05M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$497.00K	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$100.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$951.00K	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$191.00K	USD	1 Quarter
Research and development - license acquired	`ResearchAndDevelopmentLicenseAcquired`	$41.00K	USD	1 Quarter
Research and development - license acquired	`ResearchAndDevelopmentLicenseAcquired`	$1.15M	USD	3 Qtrs
Research and development - license acquired	`ResearchAndDevelopmentLicenseAcquired`	$1.13M	USD	3 Qtrs
Research and development - license acquired	`ResearchAndDevelopmentLicenseAcquired`	$3.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$5.16M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$1.78M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$966.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$6.86M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-6.86M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.78M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-966.00K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-5.16M	USD	3 Qtrs
Other income	`OtherIncome`	$19.00K	USD	3 Qtrs
Other income	`OtherIncome`	$4.00K	USD	1 Quarter
Other income	`OtherIncome`	-	USD	1 Quarter
Other income	`OtherIncome`	$135.00K	USD	3 Qtrs
Interest income	`InterestIncomeExpenseNet`	-	USD	1 Quarter
Interest income	`InterestIncomeExpenseNet`	$40.00K	USD	1 Quarter
Interest income	`InterestIncomeExpenseNet`	-	USD	3 Qtrs
Interest income	`InterestIncomeExpenseNet`	$107.00K	USD	3 Qtrs
Loss on marketable securities	`MarketableSecuritiesGainLoss`	$-3.03M	USD	1 Quarter
Loss on marketable securities	`MarketableSecuritiesGainLoss`	$-433.00K	USD	1 Quarter
Loss on marketable securities	`MarketableSecuritiesGainLoss`	$-171.00K	USD	3 Qtrs
Loss on marketable securities	`MarketableSecuritiesGainLoss`	$-2.57M	USD	3 Qtrs
Change in fair value of investment	`GainLossOnInvestments`	$-622.00K	USD	1 Quarter
Change in fair value of investment	`GainLossOnInvestments`	$-7.35M	USD	3 Qtrs
Change in fair value of investment	`GainLossOnInvestments`	$4.72M	USD	1 Quarter
Change in fair value of investment	`GainLossOnInvestments`	$3.83M	USD	3 Qtrs
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$-7.50M	USD	3 Qtrs
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$1.50M	USD	3 Qtrs
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$1.73M	USD	1 Quarter
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$-1.05M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-47.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-12.66M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-5.36M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.02M	USD	1 Quarter
Basic and Diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Basic and Diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.49	USD	3 Qtrs
Basic and Diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	3 Qtrs
Basic and Diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.06	USD	1 Quarter
Basic and Diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	34.99M	shares	1 Quarter
Basic and Diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	79.94M	shares	3 Qtrs
Basic and Diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	25.75M	shares	3 Qtrs
Basic and Diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.63M	shares	1 Quarter

Cash Flow Statement 67 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-47.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-12.66M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-5.36M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.02M	USD	1 Quarter
Change in fair value of investment	`ChangeInFairValueOfInvestments`	$7.35M	USD	3 Qtrs
Change in fair value of investment	`ChangeInFairValueOfInvestments`	$-3.83M	USD	3 Qtrs
Research and development-acquired license, expensed	`ResearchAndDevelopmentacquiredLicenseExpensed`	$1.15M	USD	3 Qtrs
Research and development-acquired license, expensed	`ResearchAndDevelopmentacquiredLicenseExpensed`	$1.13M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	-	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$314.00K	USD	3 Qtrs
Realized gain on marketable securities	`MarketableSecuritiesRealizedGainLoss`	$-583.00K	USD	1 Quarter
Realized gain on marketable securities	`MarketableSecuritiesRealizedGainLoss`	$-447.00K	USD	1 Quarter
Realized gain on marketable securities	`MarketableSecuritiesRealizedGainLoss`	$501.00K	USD	3 Qtrs
Realized gain on marketable securities	`MarketableSecuritiesRealizedGainLoss`	$97.00K	USD	3 Qtrs
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-166.00K	USD	1 Quarter
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-4.30M	USD	3 Qtrs
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-781.00K	USD	3 Qtrs
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-2.90M	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$429.00K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-135.00K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$5.00K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$30.00K	USD	3 Qtrs
Accrued salaries and benefits	`IncreaseDecreaseInAccruedSalaries`	$-321.00K	USD	3 Qtrs
Accrued salaries and benefits	`IncreaseDecreaseInAccruedSalaries`	$-73.00K	USD	3 Qtrs
Interest receivable on convertible note	`IncreaseDecreaseInNotesReceivables`	$107.00K	USD	3 Qtrs
Interest receivable on convertible note	`IncreaseDecreaseInNotesReceivables`	-	USD	3 Qtrs
Payable to DatChat	`IncreaseDecreaseInPayablesToDatchat`	$50.00K	USD	3 Qtrs
Payable to DatChat	`IncreaseDecreaseInPayablesToDatchat`	-	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.55M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.58M	USD	3 Qtrs
Purchase of marketable securities	`PurchaseOfMarketableSecurities`	$90.54M	USD	3 Qtrs
Purchase of marketable securities	`PurchaseOfMarketableSecurities`	$98.52M	USD	3 Qtrs
Sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$30.44M	USD	3 Qtrs
Sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$72.01M	USD	3 Qtrs
Proceeds from sale of Hoth common shares	`ProceedsFromSaleOfCommonStock`	$460.00K	USD	3 Qtrs
Proceeds from sale of Hoth common shares	`ProceedsFromSaleOfCommonStock`	-	USD	3 Qtrs
Proceeds from sale of DatChat common shares	`ProceedsFromSaleOfDatChatCommonShares`	$900.00K	USD	3 Qtrs
Funds to deposit accounts, net	`FundsToDepositAccounts`	-	USD	3 Qtrs
Funds to deposit accounts, net	`FundsToDepositAccounts`	$4.42M	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$4.07M	USD	3 Qtrs
Purchase of research and development licenses	`PaymentsToAcquireInProcessResearchAndDevelopment`	$597.00K	USD	3 Qtrs
Purchase of research and development licenses	`PaymentsToAcquireInProcessResearchAndDevelopment`	$1.15M	USD	3 Qtrs
Purchase of convertible note	`RepaymentOfConvertibleDebt`	-	USD	3 Qtrs
Purchase of convertible note	`RepaymentOfConvertibleDebt`	$2.00M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-70.28M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-27.21M	USD	3 Qtrs
Proceeds from issuance of common stock and warrants, net of offering cost	`ProceedsFromIssuanceCommonStockAndWarrantsNetOfOfferingCost`	$6.56M	USD	3 Qtrs
Proceeds from issuance of common stock and warrants, net of offering cost	`ProceedsFromIssuanceCommonStockAndWarrantsNetOfOfferingCost`	$77.99M	USD	3 Qtrs
Proceeds from issuance of common stock, net of offering cost	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Proceeds from issuance of common stock, net of offering cost	`ProceedsFromIssuanceOfCommonStock`	$17.84M	USD	3 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$7.20M	USD	3 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$84.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$31.61M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$78.07M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$819.00K	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$3.23M	USD	3 Qtrs
Cash and cash equivalents, beginning of period	`CashEquivalentsAtCarryingValue`	$91.00K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashEquivalentsAtCarryingValue`	$5.95M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashEquivalentsAtCarryingValue`	$2.71M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashEquivalentsAtCarryingValue`	$910.00K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashEquivalentsAtCarryingValue`	$91.00K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashEquivalentsAtCarryingValue`	$5.95M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashEquivalentsAtCarryingValue`	$2.71M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashEquivalentsAtCarryingValue`	$910.00K	USD	Point-in-time
Distribution of Hoth common stock	`DistributionOfHothCommonStock`	$269.00K	USD	3 Qtrs
Distribution of Hoth common stock	`DistributionOfHothCommonStock`	$269.00K	USD	1 Quarter
Unpaid investment	`UnpaidInvestment`	$1.00M	USD	3 Qtrs

Stockholders Equity 29 line items

Line Item	Tag	Value	Unit	Period
Warrant net offering costs	`WarrantNetOfferingCosts`	$941.00K	USD	3 Qtrs
Warrant net offering costs	`WarrantNetOfferingCosts`	$8.26M	USD	3 Qtrs
Net of offering costs	`NetOfOfferingCosts`	$1.91M	USD	3 Qtrs
Balance	`StockholdersEquity`	$103.17M	USD	Point-in-time
Balance	`StockholdersEquity`	$31.49M	USD	Point-in-time
Balance	`StockholdersEquity`	$103.08M	USD	Point-in-time
Balance	`StockholdersEquity`	$29.21M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.53M	USD	Point-in-time
Balance	`StockholdersEquity`	$29.62M	USD	Point-in-time
Issuance of common stock and warrants (net of offering costs of $8,260)	`StockIssuedDuringPeriodValueOfCommonStockAndWarrants`	$77.99M	USD	3 Qtrs
Exercise of warrants	`StockIssuedDuringPeriodValueStockOptionsExercised`	$84.00K	USD	3 Qtrs
Issuance of common stock for research and development license acquired	`StockIssuedDuringPeriodValueIssuedForResearchAndDevelopmentLicenseAcquired`	$531.00K	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition`	$139.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition`	$314.00K	USD	3 Qtrs
Issuance of common stock and warrants (net of offering costs of $8,260)	`StockIssuedDuringPeriodValueOther`	$6.56M	USD	3 Qtrs
Issuance of common stock, net of offering cost (net of offering costs of $1,905)	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$17.84M	USD	3 Qtrs
Common warrant and prefunded warrant exercise	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$7.20M	USD	3 Qtrs
Distribution of Hoth common stock	`DistributionOfHothCommonStock`	$269.00K	USD	3 Qtrs
Distribution of Hoth common stock	`DistributionOfHothCommonStock`	$269.00K	USD	1 Quarter
Net loss	`ProfitLoss`	$-5.36M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-47.00K	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.02M	USD	1 Quarter
Net loss	`ProfitLoss`	$-12.66M	USD	3 Qtrs
Balance	`StockholdersEquity`	$103.17M	USD	Point-in-time
Balance	`StockholdersEquity`	$31.49M	USD	Point-in-time
Balance	`StockholdersEquity`	$103.08M	USD	Point-in-time
Balance	`StockholdersEquity`	$29.21M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.53M	USD	Point-in-time
Balance	`StockholdersEquity`	$29.62M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.